StockData
Profusa, Inc. logo

Profusa, Inc. (PFSA) stock

PFSANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NVACW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.35+0.01 (+1.84%)

Close on Nov 18, 2026Market cap $46.89KP/E –Yield –

Profusa r&d expenses

Research and development expenses are spending on new products and technology.

Profusa's R&D Expenses for the twelve months ending Jun 30, 2026 was $3.95M, up 163.6% year over year. For fiscal 2025 it was $2.80M, up 74.4% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.80M+74.4%
FY2024Dec 31, 2024$1.61M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$823.00K+109.4%
Q1 FY2026Mar 31, 2026$1.15M+164.1%
Q4 FY2025Dec 31, 2025$1.26M+384.6%
Q3 FY2025Sep 30, 2025$722.00K+75.7%
Q2 FY2025Jun 30, 2025$393.00K–
Q1 FY2025Mar 31, 2025$434.00K–
Q4 FY2024Dec 31, 2024$259.00K–
Q3 FY2024Sep 30, 2024$411.00K–

More Profusa figures

See a number that looks wrong?